Hypoxia mimetics restore bone biomineralisation in hyperglycaemic environments

Area of Science:

• Biomaterials Science
• Cell Biology
• Orthopedics

Background:

• Diabetic patients exhibit higher fracture risks and impaired bone healing.
• Hyperglycemia and hypoxia negatively impact cellular responses, particularly the hypoxia-inducible factor 1-alpha (HIF-1α) pathway, crucial for bone regeneration.

Purpose of the Study:

• To investigate the effects of glucose levels, hypoxia, and HIF-1α stabilizing chemicals on bone formation using an in vitro model.
• To explore the potential of targeting the HIF pathway for enhancing bone regeneration in diabetic conditions.

Main Methods:

• Utilized an in vitro bone tissue engineering model under varying glucose concentrations (normal, 25 mM, 50 mM).
• Applied hypoxia (1% O2) and hypoxia mimetics (CoCl2, DMOG) to assess their impact on bone nodule formation and biomineralization.
• Employed a multidisciplinary approach for bone characterization.

Main Results:

• Hypoxia inhibited bone nodule formation and altered biomineralization patterns.
• Hyperglycemic conditions significantly inhibited biomineralization.
• Hypoxia mimetics partially restored bone nodule formation suppressed by hyperglycemia, distinct from the effects of actual hypoxia.

Conclusions:

• HIF-1α stabilization plays a role in bone biomineralization beyond neovascularization.
• Targeting the HIF pathway presents a promising therapeutic strategy for improving bone regeneration in diabetic patients.
• Osteoblast responses to hypoxia mimetics differ from actual hypoxia, highlighting the complexity of HIF-1α regulation in bone healing.